Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 7873
116th Congress(2019-2020)
Epi for Dilly Act of 2020
Introduced
Introduced
Introduced in House on Jul 30, 2020
Overview
Text
Introduced in House 
Jul 30, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jul 30, 2020)
Jul 30, 2020
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 7873 (Introduced-in-House)


116th CONGRESS
2d Session
H. R. 7873


To amend the Public Health Service Act to give a preference, with respect to project grants for preventive health services, for States that allow trained individuals to carry and administer epinephrine, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

July 30, 2020

Mr. Grothman introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Public Health Service Act to give a preference, with respect to project grants for preventive health services, for States that allow trained individuals to carry and administer epinephrine, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Epi for Dilly Act of 2020”.

SEC. 2. Preference for States that allow trained individuals to carry and administer epinephrine.

Section 317 of the Public Health Service Act (42 U.S.C. 247b) is amended by adding at the end the following new subsection:

“(n) Preference for States that allow trained individuals To carry and administer epinephrine.—

“(1) PREFERENCE.—The Secretary, in making grants under this section, shall give preference to any State that—

“(A) permits a trained individual to administer epinephrine to any individual reasonably believed to be having an anaphylactic reaction; and

“(B) provides to the Secretary the certification described in paragraph (2).

“(2) CIVIL LIABILITY PROTECTION LAW.—The certification described in this paragraph is a certification made by the attorney general of the State that the State—

“(A) has a civil liability protection law;

“(B) has reviewed such law to determine the application of such law with regard to a trained individual who may administer epinephrine to another individual reasonably believed to be having an anaphylactic reaction; and

“(C) has concluded that such law provides adequate civil liability protection applicable to such a trained individual.

“(3) RULE OF CONSTRUCTION.—Nothing in this subsection creates a cause of action or in any other way increases or diminishes the liability of any person under any other law.

“(4) DEFINITIONS.—For purposes of this subsection:

“(A) The term ‘civil liability protection law’ means a State law offering liability protection to individuals who give aid on a voluntary basis in an emergency to an individual who is ill, in peril, or otherwise incapacitated.

“(B) The term ‘trained individual’ means an individual—

“(i) who has received training in the administration of epinephrine; and

“(ii) whose training in the administration of epinephrine meets appropriate medical standards and has been approved by the State.”.